APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Amyloid Peptides

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Amyloid Peptides Industry Growth and Trends Forecast to 2032

Report ID 173963190122 December 202598 pages

Choose your research edition.

Industry ResearchAmyloid Peptides Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Amyloid Peptides Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Amyloid Peptides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Amyloid Peptides Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Amyloid Peptides Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Amyloid Peptides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Amyloid Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Amyloid Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Amyloid Peptides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Amyloid Peptides include rPeptide, NovoPro Inc., Genscript, Cambridge Research Biochemicals, Bio-Synthesis, BioLegend, Bachem, AnaSpec, Inc and AmideBio, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Amyloid Peptides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Amyloid Peptides market size, estimates, and forecasts are presented in terms of sales volume (g) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Amyloid Peptides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Amyloid Peptides.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Amyloid Peptides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Amyloid Peptides Market by Company

rPeptide

NovoPro Inc.

Genscript

Cambridge Research Biochemicals

Bio-Synthesis

BioLegend

Bachem

AnaSpec, Inc

AmideBio

Amyloid Peptides Segment by Type

Beta-Amyloid Mouse

Beta-Amyloid Human

Beta-Amyloid Rat

Amyloid Peptides Segment by Application

Cerebral Amyloid Angiopathy Research

Lewy Body Dementia Research

Inclusion Body Myositis Research

Cancer Research

Alzheimer's Disease Research

Others

Amyloid Peptides Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amyloid Peptides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Amyloid Peptides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amyloid Peptides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Amyloid Peptides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Amyloid Peptides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Beta-Amyloid Mouse Table 2. Major Company of Beta-Amyloid Human Table 3. Major Company of Beta-Amyloid Rat Table 4. Global Amyloid Peptides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Amyloid Peptides Sales by Type (2021-2026) & (g) Table 6. Global Amyloid Peptides Sales Market Share in Volume by Type (2021-2026) Table 7. Global Amyloid Peptides Sales by Type (2021-2026) & (US$ Million) Table 8. Global Amyloid Peptides Sales Market Share in Value by Type (2021-2026) Table 9. Global Amyloid Peptides Price by Type (2021-2026) & (US$/g) Table 10. Global Amyloid Peptides Sales by Type (2027-2032) & (g) Table 11. Global Amyloid Peptides Sales Market Share in Volume by Type (2027-2032) Table 12. Global Amyloid Peptides Sales by Type (2027-2032) & (US$ Million) Table 13. Global Amyloid Peptides Sales Market Share in Value by Type (2027-2032) Table 14. Global Amyloid Peptides Price by Type (2027-2032) & (US$/g) Table 15. North America Amyloid Peptides Sales by Type (2021-2026) & (g) Table 16. North America Amyloid Peptides Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Amyloid Peptides Sales by Type (2021-2026) & (g) Table 18. Europe Amyloid Peptides Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Amyloid Peptides Sales by Type (2021-2026) & (g) Table 20. Asia-Pacific Amyloid Peptides Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Amyloid Peptides Sales by Type (2021-2026) & (g) Table 22. Latin America Amyloid Peptides Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Amyloid Peptides Sales by Type (2021-2026) & (g) Table 24. Middle East and Africa Amyloid Peptides Sales by Type (2021-2026) & (US$ Million) Table 25. Amyloid Peptides Industry Trends Table 26. Amyloid Peptides Industry Drivers Table 27. Amyloid Peptides Industry Opportunities and Challenges Table 28. Amyloid Peptides Industry Restraints Table 29. Global Amyloid Peptides Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Amyloid Peptides Revenue Market Share by Company (2021-2026) Table 31. Global Amyloid Peptides Sales by Company (2021-2026) & (g) Table 32. Global Amyloid Peptides Sales Share by Company (2021-2026) Table 33. Global Amyloid Peptides Market Price by Company (2021-2026) & (US$/g) Table 34. Global Amyloid Peptides Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Amyloid Peptides Major Company Production Sites and Headquarters Table 36. Global Amyloid Peptides Company, Product Type & Application Table 37. Global Amyloid Peptides Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Amyloid Peptides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Amyloid Peptides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Amyloid Peptides Sales by Region (2021-2026) & (g) Table 42. Global Amyloid Peptides Sales Market Share in Volume by Region (2021-2026) Table 43. Global Amyloid Peptides Sales by Region (2021-2026) & (US$ Million) Table 44. Global Amyloid Peptides Sales Market Share in Value by Region (2021-2026) Table 45. Global Amyloid Peptides Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 46. Global Amyloid Peptides Sales by Region (2027-2032) & (g) Table 47. Global Amyloid Peptides Sales Market Share in Volume by Region (2027-2032) Table 48. Global Amyloid Peptides Sales by Region (2027-2032) & (US$ Million) Table 49. Global Amyloid Peptides Sales Market Share in Value by Region (2027-2032) Table 50. Global Amyloid Peptides Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2027-2032) Table 51. Global Amyloid Peptides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Amyloid Peptides Sales by Application (2021-2026) & (g) Table 53. Global Amyloid Peptides Sales Market Share in Volume by Application (2021-2026) Table 54. Global Amyloid Peptides Sales by Application (2021-2026) & (US$ Million) Table 55. Global Amyloid Peptides Sales Market Share in Value by Application (2021-2026) Table 56. Global Amyloid Peptides Price by Application (2021-2026) & (US$/g) Table 57. Global Amyloid Peptides Sales by Application (2027-2032) & (g) Table 58. Global Amyloid Peptides Sales Market Share in Volume by Application (2027-2032) Table 59. Global Amyloid Peptides Sales by Application (2027-2032) & (US$ Million) Table 60. Global Amyloid Peptides Sales Market Share in Value by Application (2027-2032) Table 61. Global Amyloid Peptides Price by Application (2027-2032) & (US$/g) Table 62. North America Amyloid Peptides Sales by Application (2021-2026) & (g) Table 63. North America Amyloid Peptides Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Amyloid Peptides Sales by Application (2021-2026) & (g) Table 65. Europe Amyloid Peptides Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Amyloid Peptides Sales by Application (2021-2026) & (g) Table 67. Asia-Pacific Amyloid Peptides Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Amyloid Peptides Sales by Application (2021-2026) & (g) Table 69. Latin America Amyloid Peptides Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Amyloid Peptides Sales by Application (2021-2026) & (g) Table 71. Middle East and Africa Amyloid Peptides Sales by Application (2021-2026) & (US$ Million) Table 72. rPeptide Company Information Table 73. rPeptide Business Overview Table 74. rPeptide Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 75. rPeptide Amyloid Peptides Product Portfolio Table 76. rPeptide Recent Development Table 77. NovoPro Inc. Company Information Table 78. NovoPro Inc. Business Overview Table 79. NovoPro Inc. Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 80. NovoPro Inc. Amyloid Peptides Product Portfolio Table 81. NovoPro Inc. Recent Development Table 82. Genscript Company Information Table 83. Genscript Business Overview Table 84. Genscript Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 85. Genscript Amyloid Peptides Product Portfolio Table 86. Genscript Recent Development Table 87. Cambridge Research Biochemicals Company Information Table 88. Cambridge Research Biochemicals Business Overview Table 89. Cambridge Research Biochemicals Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 90. Cambridge Research Biochemicals Amyloid Peptides Product Portfolio Table 91. Cambridge Research Biochemicals Recent Development Table 92. Bio-Synthesis Company Information Table 93. Bio-Synthesis Business Overview Table 94. Bio-Synthesis Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 95. Bio-Synthesis Amyloid Peptides Product Portfolio Table 96. Bio-Synthesis Recent Development Table 97. BioLegend Company Information Table 98. BioLegend Business Overview Table 99. BioLegend Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 100. BioLegend Amyloid Peptides Product Portfolio Table 101. BioLegend Recent Development Table 102. Bachem Company Information Table 103. Bachem Business Overview Table 104. Bachem Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 105. Bachem Amyloid Peptides Product Portfolio Table 106. Bachem Recent Development Table 107. AnaSpec, Inc Company Information Table 108. AnaSpec, Inc Business Overview Table 109. AnaSpec, Inc Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 110. AnaSpec, Inc Amyloid Peptides Product Portfolio Table 111. AnaSpec, Inc Recent Development Table 112. AmideBio Company Information Table 113. AmideBio Business Overview Table 114. AmideBio Amyloid Peptides Sales (g), Revenue (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 115. AmideBio Amyloid Peptides Product Portfolio Table 116. AmideBio Recent Development Table 117. North America Amyloid Peptides Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 118. North America Amyloid Peptides Sales by Country (2021-2026) & (g) Table 119. North America Amyloid Peptides Sales Market Share by Country (2021-2026) Table 120. North America Amyloid Peptides Sales Forecast by Country (2027-2032) & (g) Table 121. North America Amyloid Peptides Sales Market Share Forecast by Country (2027-2032) Table 122. North America Amyloid Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. North America Amyloid Peptides Market Size by Country (2021-2026) & (US$ Million) Table 124. North America Amyloid Peptides Market Share by Country (2021-2026) Table 125. North America Amyloid Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. North America Amyloid Peptides Market Share Forecast by Country (2027-2032) Table 127. Europe Amyloid Peptides Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 128. Europe Amyloid Peptides Sales by Country (2021-2026) & (g) Table 129. Europe Amyloid Peptides Sales Market Share by Country (2021-2026) Table 130. Europe Amyloid Peptides Sales Forecast by Country (2027-2032) & (g) Table 131. Europe Amyloid Peptides Sales Market Share Forecast by Country (2027-2032) Table 132. Europe Amyloid Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Europe Amyloid Peptides Market Size by Country (2021-2026) & (US$ Million) Table 134. Europe Amyloid Peptides Market Share by Country (2021-2026) Table 135. Europe Amyloid Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Europe Amyloid Peptides Market Share Forecast by Country (2027-2032) Table 137. Asia-Pacific Amyloid Peptides Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 138. Asia-Pacific Amyloid Peptides Sales by Country (2021-2026) & (g) Table 139. Asia-Pacific Amyloid Peptides Sales Market Share by Country (2021-2026) Table 140. Asia-Pacific Amyloid Peptides Sales Forecast by Country (2027-2032) & (g) Table 141. Asia-Pacific Amyloid Peptides Sales Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Amyloid Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Amyloid Peptides Market Size by Country (2021-2026) & (US$ Million) Table 144. Asia-Pacific Amyloid Peptides Market Share by Country (2021-2026) Table 145. Asia-Pacific Amyloid Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Asia-Pacific Amyloid Peptides Market Share Forecast by Country (2027-2032) Table 147. Latin America Amyloid Peptides Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 148. Latin America Amyloid Peptides Sales by Country (2021-2026) & (g) Table 149. Latin America Amyloid Peptides Sales Market Share by Country (2021-2026) Table 150. Latin America Amyloid Peptides Sales Forecast by Country (2027-2032) & (g) Table 151. Latin America Amyloid Peptides Sales Market Share Forecast by Country (2027-2032) Table 152. Latin America Amyloid Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Latin America Amyloid Peptides Market Size by Country (2021-2026) & (US$ Million) Table 154. Latin America Amyloid Peptides Market Share by Country (2021-2026) Table 155. Latin America Amyloid Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Latin America Amyloid Peptides Market Share Forecast by Country (2027-2032) Table 157. Middle East and Africa Amyloid Peptides Market Size Growth Rate (CAGR) by Country (g): 2021 VS 2025 VS 2032 Table 158. Middle East and Africa Amyloid Peptides Sales by Country (2021-2026) & (g) Table 159. Middle East and Africa Amyloid Peptides Sales Market Share by Country (2021-2026) Table 160. Middle East and Africa Amyloid Peptides Sales Forecast by Country (2027-2032) & (g) Table 161. Middle East and Africa Amyloid Peptides Sales Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Amyloid Peptides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Amyloid Peptides Market Size by Country (2021-2026) & (US$ Million) Table 164. Middle East and Africa Amyloid Peptides Market Share by Country (2021-2026) Table 165. Middle East and Africa Amyloid Peptides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Middle East and Africa Amyloid Peptides Market Share Forecast by Country (2027-2032) Table 167. Key Raw Materials Table 168. Raw Materials Key Suppliers Table 169. Amyloid Peptides Distributors List Table 170. Amyloid Peptides Customers List Table 171. Research Programs/Design for This Report Table 172. Authors List of This Report Table 173. Secondary Sources Table 174. Primary Sources List of Figures Figure 1. Amyloid Peptides Image Figure 2. Global Amyloid Peptides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Amyloid Peptides Market Size (2021-2032) & (US$ Million) Figure 4. Global Amyloid Peptides Sales (2021-2032) & (g) Figure 5. Beta-Amyloid Mouse Image Figure 6. Global Beta-Amyloid Mouse Sales YoY Growth (2021-2032) & (g) Figure 7. Beta-Amyloid Human Image Figure 8. Global Beta-Amyloid Human Sales YoY Growth (2021-2032) & (g) Figure 9. Beta-Amyloid Rat Image Figure 10. Global Beta-Amyloid Rat Sales YoY Growth (2021-2032) & (g) Figure 11. Global Amyloid Peptides Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Amyloid Peptides Market Share by Type 2025 VS 2032 Figure 13. North America Amyloid Peptides Sales Market Share in Volume by Type in 2025 Figure 14. North America Amyloid Peptides Sales Market Share in Value by Type in 2025 Figure 15. Europe Amyloid Peptides Sales Market Share in Volume by Type in 2025 Figure 16. Europe Amyloid Peptides Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Amyloid Peptides Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Amyloid Peptides Sales Market Share in Value by Type in 2025 Figure 19. Latin America Amyloid Peptides Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Amyloid Peptides Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Amyloid Peptides Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Amyloid Peptides Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Amyloid Peptides Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Cerebral Amyloid Angiopathy Research Image Figure 26. Global Cerebral Amyloid Angiopathy Research Sales YoY Growth (2021-2032) & (g) Figure 27. Lewy Body Dementia Research Image Figure 28. Global Lewy Body Dementia Research Sales YoY Growth (2021-2032) & (g) Figure 29. Inclusion Body Myositis Research Image Figure 30. Global Inclusion Body Myositis Research Sales YoY Growth (2021-2032) & (g) Figure 31. Cancer Research Image Figure 32. Global Cancer Research Sales YoY Growth (2021-2032) & (g) Figure 33. Alzheimer's Disease Research Image Figure 34. Global Alzheimer's Disease Research Sales YoY Growth (2021-2032) & (g) Figure 35. Others Image Figure 36. Global Others Sales YoY Growth (2021-2032) & (g) Figure 37. Global Amyloid Peptides Market Size Overview by Application (2021-2032) & (US$ Million) Figure 38. Global Amyloid Peptides Market Share by Application 2025 VS 2032 Figure 39. North America Amyloid Peptides Sales Market Share in Volume by Application in 2025 Figure 40. North America Amyloid Peptides Sales Market Share in Value by Application in 2025 Figure 41. Europe Amyloid Peptides Sales Market Share in Volume by Application in 2025 Figure 42. Europe Amyloid Peptides Sales Market Share in Value by Application in 2025 Figure 43. Asia-Pacific Amyloid Peptides Sales Market Share in Volume by Application in 2025 Figure 44. Asia-Pacific Amyloid Peptides Sales Market Share in Value by Application in 2025 Figure 45. Latin America Amyloid Peptides Sales Market Share in Volume by Application in 2025 Figure 46. Latin America Amyloid Peptides Sales Market Share in Value by Application in 2025 Figure 47. Middle East and Africa Amyloid Peptides Sales Market Share in Volume by Application in 2025 Figure 48. Middle East and Africa Amyloid Peptides Sales Market Share in Value by Application in 2025 Figure 49. North America Amyloid Peptides Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 50. North America Amyloid Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. North America Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. North America Amyloid Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Amyloid Peptides Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 54. Europe Amyloid Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Europe Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Europe Amyloid Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Amyloid Peptides Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 58. Asia-Pacific Amyloid Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Asia-Pacific Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Asia-Pacific Amyloid Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Amyloid Peptides Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 62. Latin America Amyloid Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Latin America Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Latin America Amyloid Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Amyloid Peptides Sales by Country: 2021 VS 2025 VS 2032 (g) Figure 66. Middle East and Africa Amyloid Peptides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Middle East and Africa Amyloid Peptides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Middle East and Africa Amyloid Peptides Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Amyloid Peptides Value Chain Figure 70. Key Raw Materials Price Figure 71. Manufacturing Cost Structure Figure 72. Amyloid Peptides Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Beta-Amyloid Mouse
  • Beta-Amyloid Human
  • Beta-Amyloid Rat
Applications
  • Cerebral Amyloid Angiopathy Research
  • Lewy Body Dementia Research
  • Inclusion Body Myositis Research
  • Cancer Research
  • Alzheimer's Disease Research
  • Others
Companies covered
  • rPeptide
  • NovoPro Inc.
  • Genscript
  • Cambridge Research Biochemicals
  • Bio-Synthesis
  • BioLegend
  • Bachem
  • AnaSpec, Inc
  • AmideBio

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Amyloid Peptides Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Amyloid Peptides Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Amyloid Peptides Market by Type
  6. 1.3.1 Beta-Amyloid Mouse
  7. 1.3.2 Beta-Amyloid Human
  8. 1.3.3 Beta-Amyloid Rat
  9. 1.4 Global Amyloid Peptides Market Size by Type
  10. 1.4.1 Global Amyloid Peptides Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Amyloid Peptides Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Amyloid Peptides Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Amyloid Peptides Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Amyloid Peptides Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Amyloid Peptides Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Amyloid Peptides Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Amyloid Peptides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Amyloid Peptides Industry Trends
  2. 2.2 Amyloid Peptides Industry Drivers
  3. 2.3 Amyloid Peptides Industry Opportunities and Challenges
  4. 2.4 Amyloid Peptides Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Amyloid Peptides Revenue (2021-2026)
  2. 3.2 Global Top Players by Amyloid Peptides Sales (2021-2026)
  3. 3.3 Global Top Players by Amyloid Peptides Price (2021-2026)
  4. 3.4 Global Amyloid Peptides Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Amyloid Peptides Major Company Production Sites & Headquarters
  6. 3.6 Global Amyloid Peptides Company, Product Type & Application
  7. 3.7 Global Amyloid Peptides Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Amyloid Peptides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Amyloid Peptides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Amyloid Peptides Tier 1, Tier 2, and Tier 3
4 Amyloid Peptides Regional Status and Outlook
  1. 4.1 Global Amyloid Peptides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Amyloid Peptides Historic Market Size by Region
  3. 4.2.1 Global Amyloid Peptides Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Amyloid Peptides Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Amyloid Peptides Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Amyloid Peptides Forecasted Market Size by Region
  7. 4.3.1 Global Amyloid Peptides Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Amyloid Peptides Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Amyloid Peptides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Amyloid Peptides by Application
  1. 5.1 Amyloid Peptides Market by Application
  2. 5.1.1 Cerebral Amyloid Angiopathy Research
  3. 5.1.2 Lewy Body Dementia Research
  4. 5.1.3 Inclusion Body Myositis Research
  5. 5.1.4 Cancer Research
  6. 5.1.5 Alzheimer's Disease Research
  7. 5.1.6 Others
  8. 5.2 Global Amyloid Peptides Market Size by Application
  9. 5.2.1 Global Amyloid Peptides Market Size Overview by Application (2021-2032)
  10. 5.2.2 Global Amyloid Peptides Historic Market Size Review by Application (2021-2026)
  11. 5.2.3 Global Amyloid Peptides Forecasted Market Size by Application (2027-2032)
  12. 5.3 Key Regions Market Size by Application
  13. 5.3.1 North America Amyloid Peptides Sales Breakdown by Application (2021-2026)
  14. 5.3.2 Europe Amyloid Peptides Sales Breakdown by Application (2021-2026)
  15. 5.3.3 Asia-Pacific Amyloid Peptides Sales Breakdown by Application (2021-2026)
  16. 5.3.4 South America Amyloid Peptides Sales Breakdown by Application (2021-2026)
  17. 5.3.5 Middle East and Africa Amyloid Peptides Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 rPeptide
  2. 6.1.1 rPeptide Company Information
  3. 6.1.2 rPeptide Business Overview
  4. 6.1.3 rPeptide Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 rPeptide Amyloid Peptides Product Portfolio
  6. 6.1.5 rPeptide Recent Developments
  7. 6.2 NovoPro Inc.
  8. 6.2.1 NovoPro Inc. Company Information
  9. 6.2.2 NovoPro Inc. Business Overview
  10. 6.2.3 NovoPro Inc. Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 NovoPro Inc. Amyloid Peptides Product Portfolio
  12. 6.2.5 NovoPro Inc. Recent Developments
  13. 6.3 Genscript
  14. 6.3.1 Genscript Company Information
  15. 6.3.2 Genscript Business Overview
  16. 6.3.3 Genscript Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Genscript Amyloid Peptides Product Portfolio
  18. 6.3.5 Genscript Recent Developments
  19. 6.4 Cambridge Research Biochemicals
  20. 6.4.1 Cambridge Research Biochemicals Company Information
  21. 6.4.2 Cambridge Research Biochemicals Business Overview
  22. 6.4.3 Cambridge Research Biochemicals Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Cambridge Research Biochemicals Amyloid Peptides Product Portfolio
  24. 6.4.5 Cambridge Research Biochemicals Recent Developments
  25. 6.5 Bio-Synthesis
  26. 6.5.1 Bio-Synthesis Company Information
  27. 6.5.2 Bio-Synthesis Business Overview
  28. 6.5.3 Bio-Synthesis Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Bio-Synthesis Amyloid Peptides Product Portfolio
  30. 6.5.5 Bio-Synthesis Recent Developments
  31. 6.6 BioLegend
  32. 6.6.1 BioLegend Company Information
  33. 6.6.2 BioLegend Business Overview
  34. 6.6.3 BioLegend Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 BioLegend Amyloid Peptides Product Portfolio
  36. 6.6.5 BioLegend Recent Developments
  37. 6.7 Bachem
  38. 6.7.1 Bachem Company Information
  39. 6.7.2 Bachem Business Overview
  40. 6.7.3 Bachem Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bachem Amyloid Peptides Product Portfolio
  42. 6.7.5 Bachem Recent Developments
  43. 6.8 AnaSpec, Inc
  44. 6.8.1 AnaSpec, Inc Company Information
  45. 6.8.2 AnaSpec, Inc Business Overview
  46. 6.8.3 AnaSpec, Inc Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AnaSpec, Inc Amyloid Peptides Product Portfolio
  48. 6.8.5 AnaSpec, Inc Recent Developments
  49. 6.9 AmideBio
  50. 6.9.1 AmideBio Company Information
  51. 6.9.2 AmideBio Business Overview
  52. 6.9.3 AmideBio Amyloid Peptides Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 AmideBio Amyloid Peptides Product Portfolio
  54. 6.9.5 AmideBio Recent Developments
7 North America by Country
  1. 7.1 North America Amyloid Peptides Sales by Country
  2. 7.1.1 North America Amyloid Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Amyloid Peptides Sales by Country (2021-2026)
  4. 7.1.3 North America Amyloid Peptides Sales Forecast by Country (2027-2032)
  5. 7.2 North America Amyloid Peptides Market Size by Country
  6. 7.2.1 North America Amyloid Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Amyloid Peptides Market Size by Country (2021-2026)
  8. 7.2.3 North America Amyloid Peptides Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Amyloid Peptides Sales by Country
  2. 8.1.1 Europe Amyloid Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Amyloid Peptides Sales by Country (2021-2026)
  4. 8.1.3 Europe Amyloid Peptides Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Amyloid Peptides Market Size by Country
  6. 8.2.1 Europe Amyloid Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Amyloid Peptides Market Size by Country (2021-2026)
  8. 8.2.3 Europe Amyloid Peptides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Amyloid Peptides Sales by Country
  2. 9.1.1 Asia-Pacific Amyloid Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Amyloid Peptides Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Amyloid Peptides Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Amyloid Peptides Market Size by Country
  6. 9.2.1 Asia-Pacific Amyloid Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Amyloid Peptides Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Amyloid Peptides Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Amyloid Peptides Sales by Country
  2. 10.1.1 South America Amyloid Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Amyloid Peptides Sales by Country (2021-2026)
  4. 10.1.3 South America Amyloid Peptides Sales Forecast by Country (2027-2032)
  5. 10.2 South America Amyloid Peptides Market Size by Country
  6. 10.2.1 South America Amyloid Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Amyloid Peptides Market Size by Country (2021-2026)
  8. 10.2.3 South America Amyloid Peptides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Amyloid Peptides Sales by Country
  2. 11.1.1 Middle East and Africa Amyloid Peptides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Amyloid Peptides Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Amyloid Peptides Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Amyloid Peptides Market Size by Country
  6. 11.2.1 Middle East and Africa Amyloid Peptides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Amyloid Peptides Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Amyloid Peptides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Amyloid Peptides Value Chain Analysis
  2. 12.1.1 Amyloid Peptides Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Amyloid Peptides Production Mode & Process
  7. 12.2 Amyloid Peptides Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Amyloid Peptides Distributors
  10. 12.2.3 Amyloid Peptides Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst